Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05010356 | Insulin Sensitivity After Breast Cancer | recruiting | N/A | 24 | University of CopenhagenOTHER | 1 | Aug 18, 2021 | clinicaltrials |
| NCT04993014 | Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer(HER2Cell) | recruiting | Phase 2 | 80 | AC Camargo Cancer CenterOTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT04261829 | AFT: Introduction of a Full Breast Reconstructive Method(BREAST-II) | recruiting | — | 350 | Maastricht University Medical CenterOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT04136782 | Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer | recruiting | Phase 4 | 110 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04137653 | Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT | recruiting | Phase 3 | 1,498 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04476485 | Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy | recruiting | — | 1,000 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04960839 | Prophylactic Irradiation to the Contralateral Breast for BCAs Patients(PICB) | recruiting | N/A | 323 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 2 | Jul 14, 2021 | clinicaltrials |
| NCT04947280 | Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer | recruiting | Phase 1 / Phase 2 | 120 | Fudan UniversityOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04878666 | Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy(UKT HT03_1) | recruiting | — | 20 | University Hospital TuebingenOTHER | 1 | May 7, 2021 | clinicaltrials |
| NCT04019678 | Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.(NEONOD2) | recruiting | N/A | 850 | Istituto Clinico HumanitasOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04669873 | Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery(LAPIDARY) | recruiting | N/A | 36 | Instituto Brasileiro de Controle do CancerOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04665882 | Nomogram to Predict Breast Cancer Related Lymphedema | recruiting | N/A | 600 | Wuhan UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT04646759 | Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer | recruiting | Phase 3 | 516 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT03591276 | Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer(KEYDOX) | recruiting | Phase 1 / Phase 2 | 15 | Shaare Zedek Medical CenterOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT04481763 | A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast | recruiting | Phase 1 / Phase 2 | 20 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04481932 | Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer | recruiting | Phase 2 | 104 | Peking UniversityOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04072653 | Sentinel Node Biopsy Vs Observation After Axillary PET(SOAPET) | recruiting | N/A | 1,528 | Fudan UniversityOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT03667417 | Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation(GENEPSO) | recruiting | — | 5,000 | Institut Paoli-CalmettesOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04437160 | Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy | recruiting | Phase 2 | 286 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 18, 2020 | clinicaltrials |
| NCT04158843 | Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis(BOMB) | recruiting | N/A | 183 | xuexin heOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT04281641 | Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer(PHC-BC) | recruiting | N/A | 94 | Fudan UniversityOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT04356235 | Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques | recruiting | — | 528 | National Institute of Oncology, HungaryOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT04349527 | Comparison of the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Round-block and Retroglandular Oncoplastic Breast Conserving Surgeries | recruiting | — | 242 | National Institute of Oncology, HungaryOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT04172753 | Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac | recruiting | N/A | 472 | University Hospital TuebingenOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT04025164 | Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery | recruiting | N/A | 4,052 | Fudan UniversityOTHER | 1 | Jul 18, 2019 | clinicaltrials |
| NCT03561740 | A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients(SMART) | recruiting | Phase 3 | 794 | Sun Yat-sen UniversityOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03392233 | Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors | recruiting | Phase 2 | 100 | RenJi HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT01185132 | Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy(2009-APBI) | recruiting | Phase 3 | 660 | Rocky Mountain Cancer CentersOTHER | 1 | Jun 26, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Aug 18, 2021source: clinicaltrials